These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 29895851)

  • 1. Evaluation of polygenic risk models using multiple performance measures: a critical assessment of discordant results.
    Martens FK; Tonk ECM; Janssens ACJW
    Genet Med; 2019 Feb; 21(2):391-397. PubMed ID: 29895851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Asymptotic distribution of ∆AUC, NRIs, and IDI based on theory of U-statistics.
    Demler OV; Pencina MJ; Cook NR; D'Agostino RB
    Stat Med; 2017 Sep; 36(21):3334-3360. PubMed ID: 28627112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating the effect of multiple genetic risk score models on colorectal cancer risk prediction.
    Xin J; Chu H; Ben S; Ge Y; Shao W; Zhao Y; Wei Y; Ma G; Li S; Gu D; Zhang Z; Du M; Wang M
    Gene; 2018 Oct; 673():174-180. PubMed ID: 29908285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A note on the evaluation of novel biomarkers: do not rely on integrated discrimination improvement and net reclassification index.
    Hilden J; Gerds TA
    Stat Med; 2014 Aug; 33(19):3405-14. PubMed ID: 23553436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical use of polygenic risk scores for detection of peripheral artery disease and cardiovascular events.
    Omiye JA; Ghanzouri I; Lopez I; Wang F; Cabot J; Amal S; Ye J; Lopez NG; Adebayo-Tijani F; Ross EG
    PLoS One; 2024; 19(5):e0303610. PubMed ID: 38758931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simpson's paradox in the integrated discrimination improvement.
    Chipman J; Braun D
    Stat Med; 2017 Dec; 36(28):4468-4481. PubMed ID: 29160558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating a New Risk Marker's Predictive Contribution in Survival Models.
    Liu M; Kapadia AS; Etzel CJ
    J Stat Theory Pract; 2010 Dec; 4(4):845-855. PubMed ID: 22984361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small improvement in the area under the receiver operating characteristic curve indicated small changes in predicted risks.
    Martens FK; Tonk EC; Kers JG; Janssens AC
    J Clin Epidemiol; 2016 Nov; 79():159-164. PubMed ID: 27430730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multicategory reclassification statistics for assessing improvements in diagnostic accuracy.
    Li J; Jiang B; Fine JP
    Biostatistics; 2013 Apr; 14(2):382-94. PubMed ID: 23197381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incremental value of rare genetic variants for the prediction of multifactorial diseases.
    Mihaescu R; Pencina MJ; Alonso A; Lunetta KL; Heckbert SR; Benjamin EJ; Janssens AC
    Genome Med; 2013; 5(8):76. PubMed ID: 23961719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of Maternal Weight in the Hierarchy of Macrosomia Predictors; Overall Effect of Analysis of Three Prediction Indicators.
    Lewandowska M
    Nutrients; 2021 Feb; 13(3):. PubMed ID: 33671089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single Measurements of Carboxy-Terminal Fibroblast Growth Factor 23 and Clinical Risk Prediction of Adverse Outcomes in CKD.
    Edmonston D; Wojdyla D; Mehta R; Cai X; Lora C; Cohen D; Townsend RR; He J; Go AS; Kusek J; Weir MR; Isakova T; Pencina M; Wolf M;
    Am J Kidney Dis; 2019 Dec; 74(6):771-781. PubMed ID: 31445926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inference for reclassification statistics under nested and non-nested models for biomarker evaluation.
    Shao F; Li J; Fine J; Wong WK; Pencina M
    Biomarkers; 2015; 20(4):240-52. PubMed ID: 26301882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Net Reclassification Index and Integrated Discrimination Index Are Not Appropriate for Testing Whether a Biomarker Improves Predictive Performance.
    Burch PM; Glaab WE; Holder DJ; Phillips JA; Sauer JM; Walker EG
    Toxicol Sci; 2017 Mar; 156(1):11-13. PubMed ID: 27815493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measures for evaluation of prognostic improvement under multivariate normality for nested and nonnested models.
    Enserro DM; Demler OV; Pencina MJ; D'Agostino RB
    Stat Med; 2019 Sep; 38(20):3817-3831. PubMed ID: 31211443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New metrics for assessing diagnostic potential of candidate biomarkers.
    Pickering JW; Endre ZH
    Clin J Am Soc Nephrol; 2012 Aug; 7(8):1355-64. PubMed ID: 22679181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical risk reclassification at 10 years.
    Cook NR; Demler OV; Paynter NP
    Stat Med; 2017 Dec; 36(28):4498-4502. PubMed ID: 29156504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The power-integrated discriminant improvement: An accurate measure of the incremental predictive value of additional biomarkers.
    Hayashi K; Eguchi S
    Stat Med; 2019 Jun; 38(14):2589-2604. PubMed ID: 30859601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing improvement in disease prediction using net reclassification improvement: impact of risk cut-offs and number of risk categories.
    Mühlenbruch K; Heraclides A; Steyerberg EW; Joost HG; Boeing H; Schulze MB
    Eur J Epidemiol; 2013 Jan; 28(1):25-33. PubMed ID: 23179629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing the performance of prediction models: a framework for traditional and novel measures.
    Steyerberg EW; Vickers AJ; Cook NR; Gerds T; Gonen M; Obuchowski N; Pencina MJ; Kattan MW
    Epidemiology; 2010 Jan; 21(1):128-38. PubMed ID: 20010215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.